The study published in Science Advances on March 27 by Professor Zhang Yu of Shenyang Pharmaceutical University explores the use of exosomes derived from pig semen as a drug delivery method for retinoblastoma, a rare eye cancer in children. These engineered exosomes, formulated into eye drops, can penetrate deep into retinal tissue and cross biological barriers safely. The research highlights their potential to deliver therapeutics across the blood-brain barrier, which could be applied in treating neurological conditions such as Alzheimer's disease. Zhao Chunxia, a drug delivery researcher at the University of Adelaide, Australia, commented on the broader implications of the technology, noting its applicability beyond ocular treatments.
The research from Shenyang Pharmaceutical University opens a new pathway in biomedical delivery mechanisms using natural nanoparticles. Nigerian students pursuing neuroscience or pharmaceutical studies may find emerging opportunities in cross-disciplinary research involving biomaterials and neurodegenerative diseases.
